OpenCompanies

Nanogenics Limited

Company number
07636591
Status
Active
Type
Private Limited Company
Incorporated
17 May 2011
Nature of business
Research and experimental development on biotechnology
Corporate group
Thalia Therapeutics PLC (3 companies)

Registered office

Co Arch Law Level 2 Huckletree
8 Bishopsgate
London
EC2N 4BQ

Previous names

  • Nanogenic Solutions Limited (until 18 Jun 2018)

Officers

NameRoleAppointedResigned
CAIRNS, Luke Director 5 Oct 2023
THEOBALD, Nigel James Director 5 Oct 2023
MURRAY, Paul Director 10 Aug 2021

Control

NameNature of controlNotifiedCeased
Applisci Ltd Ownership Of Shares 25 To 50 Percent
Voting Rights 25 To 50 Percent
30 Jun 2016 11 May 2018
Prof Stephen Lewis Hart Ownership Of Shares 25 To 50 Percent
Voting Rights 25 To 50 Percent
6 Apr 2016 11 May 2018
Ryboquin Company Ltd Ownership Of Shares 50 To 75 Percent
Voting Rights 50 To 75 Percent
Right To Appoint And Remove Directors
11 May 2018 5 Oct 2023
Thalia Therapeutics Plc Ownership Of Shares 50 To 75 Percent
Voting Rights 50 To 75 Percent
5 Oct 2023

Accounts

Year ended Net assets Cash Employees
31 Dec 2024 - - -
31 Dec 2023 - - -
31 May 2023 - - -
31 May 2022 - - -
31 May 2021 - - 0
31 May 2020 - - 0
31 May 2019 - - -
31 May 2018 £83,953 - -
31 May 2017 £151,573 - -
31 May 2016 - £22,311 -
31 May 2015 - £34,230 -
31 May 2014 - £10,787 -
31 May 2013 - £14,882 -
31 May 2012 £13,480 £23,015 -

Connections

Owned by

Nanogenics Limited → Thalia Therapeutics PLC

Companies at the same address

Data